JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.72B |
| 2 |
Amazon
AMZN
|
+$2.99B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.6B |
| 4 |
Mastercard
MA
|
+$1.47B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.31B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.62B |
| 2 |
Apple
AAPL
|
+$3.37B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$1.93B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.93B |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$1.64B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.1% |
| 2 | Technology | 18.95% |
| 3 | Healthcare | 10.56% |
| 4 | Financials | 9.04% |
| 5 | Consumer Discretionary | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
JPMorgan Small & Mid Cap Enhanced Equity ETF
JMEE
$2.91B
| $590M | 0.07% |
12,180,961
-31,280
| -0.3% | -$1.58M |
2022 Q2
5 quarters
|
|
277
iShares Core US Aggregate Bond ETF
AGG
$136B
| $587M | 0.06% |
6,243,014
+979,881
| +19% | +$94.4M |
2013 Q2
41 quarters
|
|
278
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$18.3B
| $585M | 0.06% |
5,839,292
+2,435,179
| +72% | +$243M |
2013 Q2
41 quarters
|
|
|
HZNP
279
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $583M | 0.06% |
5,042,293
-448,947
| -8% | -$48.2M |
2014 Q4
35 quarters
|
|
280
Colgate-Palmolive
CL
$70.5B
| $583M | 0.06% |
8,193,235
-2,919,949
| -26% | -$218M |
2013 Q2
41 quarters
|
|
281
iShares TIPS Bond ETF
TIP
$14.2B
| $579M | 0.06% |
5,577,654
+835,933
| +18% | +$88.5M |
2013 Q2
41 quarters
|
|
282
Packaging Corp of America
PKG
$20.5B
| $576M | 0.06% |
3,753,241
-210,063
| -5% | -$30.7M |
2013 Q2
41 quarters
|
|
283
Micron Technology
MU
$1.17T
| $566M | 0.06% |
8,313,541
+4,521,230
| +119% | +$303M |
2013 Q2
41 quarters
|
|
284
Keysight
KEYS
$65B
| $561M | 0.06% |
4,241,936
-603,325
| -12% | -$89.4M |
2014 Q4
35 quarters
|
|
285
Monolithic Power Systems
MPWR
$67.3B
| $561M | 0.06% |
1,213,642
-50,646
| -4% | -$25.9M |
2014 Q2
37 quarters
|
|
286
Sarepta Therapeutics
SRPT
$1.89B
| $559M | 0.06% |
4,608,315
+204,222
| +5% | +$23.1M |
2015 Q4
31 quarters
|
|
287
Teradyne
TER
$63B
| $556M | 0.06% |
5,537,055
-2,375,007
| -30% | -$250M |
2013 Q2
41 quarters
|
|
288
iShares Core Universal USD Bond ETF
IUSB
$48.2B
| $553M | 0.06% |
12,643,991
+12,581,200
| +20,037% | +$562M |
2020 Q2
13 quarters
|
|
289
Church & Dwight Co
CHD
$23.2B
| $552M | 0.06% |
6,027,312
+2,839,783
| +89% | +$272M |
2013 Q2
41 quarters
|
|
290
UBS Group
UBS
$147B
| $551M | 0.06% |
22,334,164
+2,052,954
| +10% | +$48M |
2014 Q4
35 quarters
|
|
|
CFLT
291
DELISTED
Confluent
CFLT
| $549M | 0.06% |
18,531,163
+729,379
| +4% | +$24.4M |
2021 Q2
9 quarters
|
|
292
Estee Lauder
EL
$35.6B
| $548M | 0.06% |
3,790,848
-131,369
| -3% | -$21.9M |
2013 Q2
41 quarters
|
|
293
Kimco Realty
KIM
$14.8B
| $547M | 0.06% |
31,120,015
+5,894,446
| +23% | +$114M |
2013 Q2
41 quarters
|
|
294
Alnylam Pharmaceuticals
ALNY
$31B
| $547M | 0.06% |
3,086,846
-46,128
| -1% | -$8.8M |
2013 Q2
41 quarters
|
|
295
iShares MSCI EAFE Value ETF
EFV
$30.3B
| $545M | 0.06% |
11,139,913
+4,090,258
| +58% | +$203M |
2014 Q3
36 quarters
|
|
296
ITT
ITT
$18.1B
| $542M | 0.06% |
5,535,181
-125,349
| -2% | -$12.3M |
2013 Q2
41 quarters
|
|
297
TechnipFMC
FTI
$27.5B
| $540M | 0.06% |
26,525,442
+4,788,567
| +22% | +$90.4M |
2013 Q2
41 quarters
|
|
298
JPMorgan BetaBuilders US Small Cap Equity ETF
BBSC
$712M
| $538M | 0.06% |
10,063,691
-1,255,844
| -11% | -$71.7M |
2021 Q1
10 quarters
|
|
299
Alexandria Real Estate Equities
ARE
$7.8B
| $532M | 0.06% |
5,315,732
-332,131
| -6% | -$38.6M |
2013 Q2
41 quarters
|
|
300
PUT
iShares Silver Trust
SLV
$29.6B
| $528M | 0.06% |
25,938,100
-6,320,100
| -20% | -$137M |
2019 Q2
17 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2023 Portfolio in Review
As of Q3 2023, JP Morgan Chase held 7,912 positions worth $906B, down 1.5% from $920B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
JP Morgan Chase's Q3 2023 filing shows 1,008 new, 2,453 increased, 3,090 reduced and 491 closed positions. Its largest new stake was JPMorgan Global Select Equity ETF: 18,266,376 shares worth $849M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.62B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q3 2023 buy was JPMorgan Global Select Equity ETF: 18,266,376 shares worth $849M.
- JP Morgan Chase added most to iShares Core S&P 500 ETF in Q3 2023, an estimated $3.72B increase.
- JP Morgan Chase's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.62B.
- JP Morgan Chase fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $314M.
- JP Morgan Chase's ten largest holdings make up 19% of its $906B portfolio in Q3 2023.
- JP Morgan Chase opened 1,008 new positions and closed 491 in Q3 2023.
- JP Morgan Chase's portfolio value fell 1.5% quarter-over-quarter to $906B.
Based on JP Morgan Chase's 13F filing for Q3 2023, filed 14 Nov 2023.